Delayed entry into HIV care after diagnosis in two specialized care and treatment centres in Cameroon: the influence of CD4 count and WHO staging

Abstract

BackgroundDelayed entry into HIV care has complicated the challenges faced in sub-Saharan Africa due to the high HIV burden. A clear knowledge of the factors affecting delayed entry will be essential in directing interventions towards reducing delayed entry into HIV care. There exist very limited data on delayed entry in Cameroon despite its relevance; hence this study was conducted to determine the rate of delayed entry and its associated factors in HIV programmes in Cameroon.MethodsData used for this study was routine data obtained from the files of HIV patients who were diagnosed between January 1, 2015 and June 30, 2015 at Limbe and Buea regional hospital HIV centers in the South West region of Cameroon. Data analysis was done using SPSS version 20.ResultsOf the 223 patients included in the study, nearly one-quarter of patients (22.4 %) delayed to enter HIV care within 3 months. Those who delayed to enter care were less likely to present at first diagnosis (using HIV rapid test) with symptoms such as fever > 1 month (5 % versus 30 %, p = 0.01) and weight loss > 10 % (13 % versus 48 %, p < 0.001). Alcohol consumption, WHO stage and CD4 count levels were also associated with delayed entry in bivariate analysis. In multivariate analysis only CD4 count greater than 500cells/μl and WHO stages I and II were independently associated with delayed entry into HIV care within 3 months.ConclusionIn the South West region of Cameroon, approximately 1 out of 4 patients delay to enter HIV care. This high proportion of patients who delay to enter care correlates to the findings recorded by other studies in sub Saharan Africa. Interventions tackling delayed entry into HIV care might need to be favorably directed towards patients that have high CD4 counts and are at very early WHO clinical stages.

Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study

“…Moreover, our finding that participants' selection of "medical reasons" for initiating ART contributed to late initiation suggests that some individuals are waiting until their health is compromised to start treatment. This is supported by the literature that indicates better health or lack of physical HIV symptoms is associated with delayed linkage to care (Hanna et al, 2013;Takah et al, 2016), delayed diagnosis (Lee et al, 2010;Ndiaye et al, 2011) and treatment breaks (Begley, McLaws, Ross, & Gold, 2008;Newman et al, 2015). Counseling on the benefits and costs of ART, including peer support programs or peer-developed information resources, may help address individual-level barriers to initiating and remaining on ART.…”

Late presentation for HIV care in Southwest Ethiopia in 2003–2015: prevalence, trend, outcomes and risk factors

“…Furthermore, focus has to be given for Tb/HIV co-infection, as Tb remains the highest mortality risk among HIV infected patients [ 13 ]. The absence of previous history of HIV testing in association with LP could be linked with poor awareness of the care [ 3 ], less access to HIV testing and/or ART clinic [ 39 ], high HIV related stigma [ 67 ], fear of diagnosis [ 68 ] and feeling of wellbeing [ 69 ].HIV patients who were enrolled for HIV care in 2012 and after were less likely to present late for HIV care as compared to those enrolled in 2011 and before. This may be attributed to: i) improving awareness to HIV care; ii) improving access and availability to HIV care; and iii) reducing perceived HIV related stigma.…”

Time to anti-retroviral therapy among people living with HIV enrolled into care in Myanmar: how prepared are we for ‘test and treat’?

“…Third, a high CD4 count has been previously associated with delay in enrolment and long time to ART [7,9]. The long time to ART may be explained by delay in becoming eligible for ART.…”